R&D Credit Amortization: What the 5-Year Rule Means for Your 2026 Tax Bill
R&D Credit Amortization rules changed when businesses lost the option to deduct research expenses right away. The Tax Cuts and Jobs Act provisions took effect in 2022. Companies now face Section 174 amortization requirements that spread deductions over five years. To name just one example, a company spending $1,000,000 on domestic R&D expenses can deduct only $100,000 in year one under the current rules. This change from immediate R&D expensing to mandatory amortization of R&D expenses has created cash flow challenges for businesses investing in innovation.
We understand how the coordination between the R&D tax credit and Section 174 amortization can affect your 2026 tax bill. In this piece, we walk you through the five-year rule mechanics and how domestic and foreign R&D amortization is different. You’ll also learn strategies to maximize your combined tax benefits and recent legislative changes that may restore immediate expensing options for your business.
Understanding Section 174 Amortization and the 5-Year Rule
What Changed Under the Tax Cuts and Jobs Act
The Tax Cuts and Jobs Act of 2017 heavily amended Section 174 and eliminated the option to expense specified research or experimental (SRE) expenditures right away. Businesses must capitalize and amortize domestic R&E expenditures over five years and foreign research over 15 years for tax years beginning after December 31, 2021. This represents a fundamental change from pre-2022 treatment, where companies could either deduct qualified R&E costs in the year incurred or amortize them over at least 60 months.
The TCJA also mandated that all software development costs be treated as SRE expenditures under Section 174(c)(3). Revenue Procedure 2000-50 became obsolete for software development costs paid or incurred in taxable years beginning after December 31, 2021. Section 174 covers a broader scope than the Section 41 R&D tax credit and includes allocable overhead costs such as rent, utilities, and equipment depreciation.
How the Mid-Year Convention Works
Section 174 amortization begins with the midpoint of the taxable year in which expenses are paid or incurred. This mid-year convention treats all R&D expenses in a given year as incurred at the halfway point and affects the calculation and timing of deductions. The first year deduction represents only half of the annual amortization amount. A taxpayer incurring $1.00 million in Section 174 research expenses would receive a current year deduction of only $100,000 with the five-year amortization and half-year convention. This creates a 90% reduction from the original deduction amount and increases taxable income by $900,000.
Domestic vs. Foreign R&D Expenses
Foreign research or experimental expenditures must be amortized over a 15-year period. Taxpayers must look to where the SRE activities are performed to determine SRE expenditures attributable to foreign research. The definition of foreign research lines up with Section 41 and means any research conducted outside the United States, the Commonwealth of Puerto Rico, or any U.S. territory or possession.
Section 174(d) prohibits immediate recovery of unamortized basis in foreign capitalized R&E expenditures upon disposition, retirement, or abandonment of property. Amortization deductions must continue even after property disposal.
How R&D Amortization Affects Your 2026 Tax Bill
Current Tax Year Deductions Under the 5-Year Rule
The five-year amortization with mid-year convention alters fundamentally how much you can deduct in the year you invest in R&D. Section 174 amortization allows companies to deduct only 10% of their R&D costs in the investment year instead of the full amount. To name just one example, a business that incurs $500,000 in domestic research expenses receives a current year deduction of $50,000. This creates an immediate 90% reduction from what you could claim previously.
The mechanics work differently than standard depreciation. Expenses are treated as incurred at the midpoint of your taxable year. The first-year deduction equals half of what you’ll receive in subsequent years. Years two through five each allow 20% deductions, and the final 10% is claimed in year six.
Effect on Cash Flow and Taxable Income
The transition to mandatory amortization of R&D expenses hit innovation-focused businesses hard. Companies deferred more than $59 billion in tax benefits, cutting the after-tax value of R&D investments in half. Research-intensive public companies reduced their R&D spending by 11.6% in just the first year following implementation.
Cash flow constraints forced many businesses to cut back on share buybacks and capital spending. Higher tax bills had to be managed. Startups and growth-stage companies face unexpected tax liabilities despite operating at losses. This complicates financial planning and fundraising efforts.
Software Development Costs and Section 174
All amounts paid or incurred in connection with software development are treated as R&E expenditures eligible for Section 174 amortization. This has planning, designing, writing source code and testing until placed in service. Attorney fees, utilities and equipment depreciation allocable to software development also fall under Section 174. This creates broader capitalization requirements than many technology companies anticipated.
R&D Tax Credit and Amortization: How They Work Together
Section 41 R&D Credit Basics
Section 41 R&D tax credit calculations remain unchanged despite Section 174 amortization requirements. But not all expenses subject to Section 174 amortization qualify for the R&D tax credit. To claim the credit, expenses must meet the four-part test for Qualified Research Activities: technological in nature, eliminate uncertainty, permit experimentation, and relate to a new or improved business component.
You can calculate credits using two methods. The Regular Research Credit equals 20% of current-year Qualified Research Expenses (QREs) that exceed a calculated base amount from historical spending. The Alternative Simplified Credit offers 14% of QREs exceeding 50% of the three-year average and drops to 6% for companies without prior QRE history.
Coordinating Credits with Amortized Deductions
Section 174 covers broader expenses than Section 41, including overhead and administrative costs. Contract research expenses illustrate this gap. While 100% of contract research costs fall under Section 174, only 65% of qualified third-party research payments count toward R&D credits.
The timing creates a most important disconnect. Businesses can claim R&D credits right away in the year they incur expenses, but Section 174 amortization spreads deductions over five years. Businesses receive upfront credit benefits while losing immediate deduction value.
Section 280C Coordination Requirements
Section 280C prevents double benefits by requiring coordination between credits and deductions. Businesses must reduce their Section 174 deductions by the amount of Section 41 credit claimed. You can elect a reduced credit under Section 280C(c)(3) as an alternative and calculate the credit at about 79% of the gross amount (gross credit minus the product of gross credit and the 21% corporate tax rate).
How to Maximize Combined Tax Benefits
Calculate Section 41 expenses first when you determine Section 174 expenditures, as this concurrent approach prevents misclassification. Front-loading R&D investments into high-taxable-income years maximizes immediate credit value while managing the delayed amortization impact.
Recent Legislative Changes and What They Mean for 2026
Section 174A and the Return of R&D Expensing
The One Big Beautiful Bill Act repealed Section 174 amortization through new Section 174A and restored immediate expensing for domestic R&D expenses. Companies can deduct U.S.-based research costs in the year incurred starting in 2025. Foreign R&D expenses still require 15-year amortization.
Transition Relief Options for Previous Years
Businesses above $31 million in average annual gross receipts cannot claim retroactive relief but may accelerate unamortized R&D deductions from 2022-2024. You can deduct the remaining balance in 2025, spread it across 2025 and 2026, or continue the original five-year amortization.
Small Business Retroactive Benefits
Small businesses with average annual gross receipts of $31 million or less can apply Section 174A retroactively to tax years after December 31, 2021. This allows amending 2022, 2023, and 2024 returns to deduct R&D expenses previously amortized and claim refunds. The retroactive election must be made within one year of enactment, which creates a July 6, 2026 deadline. Keep in mind that you must amend all affected years; you cannot selectively choose which returns to revise.
State Tax Conformity Issues
State treatment of Section 174A varies based on conformity structures. Rolling conformity states adopt federal changes automatically unless they decouple explicitly, while static conformity states require legislative updates to recognize Section 174A. Several states including Michigan and Pennsylvania have taken positions on conformity already.
Conclusion
Section 174 amortization created substantial cash flow challenges for businesses driven by innovation, notwithstanding that the new Section 174A provisions restore immediate expensing for domestic R&D starting in 2025. Small businesses especially benefit from retroactive relief options, though you must act before the July 6, 2026 deadline to amend previous returns.
We recommend reviewing your R&D expenses to maximize combined credit and deduction benefits right away. You should coordinate with your tax advisor and determine whether accelerated deductions or retroactive amendments make sense for your specific situation.
Key Takeaways
Understanding the intersection of R&D credit amortization and the 5-year rule is crucial for managing your 2026 tax obligations and maximizing available benefits.
• Section 174 forces 5-year amortization of domestic R&D costs, allowing only 10% deduction in year one instead of immediate full expensing, creating significant cash flow challenges for innovation-focused businesses.
• R&D tax credits remain immediately claimable while deductions spread over five years, creating timing mismatches that require careful coordination under Section 280C to avoid double benefits.
• New Section 174A restores immediate R&D expensing starting in 2025 for domestic expenses, while small businesses under $31M in receipts can retroactively amend 2022-2024 returns.
• Small businesses must act before July 6, 2026 deadline to claim retroactive relief by amending all affected tax years and recovering previously amortized R&D deductions.
• Calculate Section 41 R&D credit expenses first when determining Section 174 expenditures to prevent misclassification and optimize the combined tax benefits from credits and deductions.
The legislative changes provide significant relief opportunities, but timing and proper coordination between credits and amortization remain critical for maximizing your tax benefits while maintaining compliance.
FAQs
Q1. How long do companies need to amortize R&D expenses under current tax law? Beginning in 2022, all costs related to research and development must be amortized over five years for US-based companies or 15 years for non-US companies. This replaced the previous system where businesses could immediately deduct these expenses in the year they were incurred.
Q2. Can businesses still claim the R&D tax credit immediately? Yes, R&D tax credits under Section 41 can still be claimed immediately in the year expenses are incurred. However, the deductions for those same expenses must be spread over five years through amortization, creating a timing difference between when you receive the credit benefit and when you can fully deduct the costs.
Q3. Has the requirement to amortize R&D expenses been eliminated? For tax years beginning after December 31, 2024, domestic R&D expenses can once again be immediately and fully deducted through new Section 174A provisions. This restores immediate expensing for US-based research activities, though foreign R&D expenses still require 15-year amortization.
Q4. How much can a company deduct in the first year under the 5-year amortization rule? Under the five-year amortization with mid-year convention, companies can only deduct 10% of their R&D costs in the year they invest. For example, if you spend $500,000 on domestic research, you can only deduct $50,000 in the first year, representing a 90% reduction from full immediate expensing.
Q5. Can small businesses retroactively claim R&D deductions for previous years? Yes, small businesses with average annual gross receipts of $31 million or less can apply Section 174A retroactively to tax years beginning after December 31, 2021. This allows them to amend their 2022, 2023, and 2024 returns to deduct R&D expenses that were previously amortized, but they must act before the July 6, 2026 deadline.
